Sinovac, Sinopharm show safety, efficacy: WHO
GENEVA -- Chinese vaccine makers Sinopharm and Sinovac have presented data on their COVID-19 vaccines demonstrating safety and good efficacy against symptomatic COVID-19 disease, a vaccine expert from the World Health Organization (WHO) has said recently.
During a news briefing on March 31, Alejandro Cravioto, chair of the WHO Strategic Advisory Group of Experts on Immunization (SAGE), said the information that the companies shared publicly at the SAGE meeting last week clearly indicates "they have levels of efficacy that would be compatible with the requirements that WHO has asked for this vaccine."
"They have all the safety data to show that this vaccine would cause no harm in humans when used," Cravioto added.
- Plan to boost eye care services by 2030
- China sees wider healthcare access as system continues to grow
- China moves to further improve family doctor services
- China targets better health for all by 2030
- China targets average life expectancy of 80 by 2030 in new five-year health plan
- The number of assisted reproductive institutions reaches 645 in China


